Related Experiment Video
Updated: Mar 10, 2026

06:28
E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
9.3K
Announcements Versus Conversations to Improve HPV Vaccination Coverage: A Randomized Trial
Noel T Brewer1,2, Megan E Hall3, Teri L Malo2
1Department of Health Behavior, Gillings School of Global Public Health, and ntb@unc.edu.
Pediatrics
|December 13, 2016
Summary
Provider training using presumptive "announcements" significantly increased human papillomavirus (HPV) vaccine initiation in adolescents aged 11-12. Conversation-based training showed no significant impact on HPV vaccination coverage.
Area of Science:
- Public Health
- Vaccinology
- Clinical Trials
Background:
- Low human papillomavirus (HPV) vaccination coverage is a significant public health concern.
- Provider recommendations play a crucial role in improving vaccination rates.
- Novel training strategies are needed to enhance provider communication regarding HPV vaccination.
Purpose of the Study:
- To evaluate the effectiveness of two distinct provider training methods—presumptive announcements and participatory conversations—on HPV vaccination coverage.
- To determine if these training interventions can improve HPV vaccine initiation in adolescents.
Main Methods:
- A parallel-group randomized clinical trial was conducted across 30 pediatric and family medicine clinics.
- Clinics were randomized to receive no training (control), announcement training, or conversation training.
- The primary outcome was the 6-month change in HPV vaccine initiation (≥1 dose) for adolescents aged 11 or 12 years, measured via the North Carolina Immunization Registry.
Main Results:
- Six-month HPV vaccination coverage increased by 5.4% in clinics utilizing announcement training compared to control clinics.
- Announcement training demonstrated effectiveness for both girls (4.6% increase) and boys (6.2% increase).
- Conversation training did not yield a significant difference in HPV vaccination coverage compared to control clinics. No significant changes were observed for other vaccines or older adolescents (13-17 years).
Conclusions:
- Training healthcare providers to use presumptive announcements is an effective strategy for increasing HPV vaccine initiation in young adolescents.
- This approach offers a clinically meaningful improvement in HPV vaccination rates for the target age group.
- Further research may be needed to optimize strategies for older adolescents and other vaccination outcomes.
Related Concept Videos
Cancer Vaccines
1.2K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K
Randomized Experiments
9.2K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Simple randomization
Simple...
9.2K
Vaccinations
53.0K
Overview
53.0K
Clinical Trials: Overview
5.2K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.2K
Clinical Trials
11.0K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
11.0K
Hazard Ratio
677
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
677

